Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

781 - 790 of 866 results found

Building Integrated Testing Programs for Infectious Diseases

Date
Wednesday, April 12, 2023 - 4:00 AM
Description
In the past two decades, testing services for diseases such as HIV, TB and malaria have expanded dramatically. Investments in testing capacity and supportive health systems have often been disease specific, resulting in siloed testing programs with

Brodalumab: 4-Year US Pharmacovigilance Report

Date
Friday, April 07, 2023 - 4:00 AM
Description
Brodalumab is an interleukin-17 receptor A antagonist approved for the treatment of moderate-to-severe psoriasis in adults without response or with loss of response to other systemic therapies. Brodalumab carries a boxed warning in the United States